Drawing for WINDTREE THERAPEUTICS

USPTO serial 86830115

WINDTREE THERAPEUTICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
COGAN, BRITTNEY LORRAINE
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with WINDTREE THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robert D. Ward

Robert D. Ward Potter Anderson & Corroon LLP1313 North Market StreetWilmington, DE 19801UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations and substances for treatment of upper and lower respiratory diseases and disorders; Pharmaceutical preparations, namely, synthetic pulmonary surfactants for treatment of respiratory conditionsACTIVE—
010Medical device, namely, a device for improving delivery of liquid, powder or aerosolized pharmaceutical preparations and substances; Medical device, namely, a device for improving delivery of liquid, powder or aerosolized pharmaceutical preparations and substances for treatment of various medical conditions; Medical device, namely, an adapter for facilitating entrainment of liquid, powder or aerosolized pharmaceutical preparations and substances; Medical devices for heating medication, namely, a dry block heater for heating medication; aerosol dispensers for medical use not filled with pharmaceuticals; medical apparatus which uses heat to generate aerosolized pharmaceutical preparations and substances which is then delivered to patientsACTIVE—
042Pharmaceutical research, drug discovery, and drug development services; medical and scientific research in the field of pulmonary diseases; research and development of pharmaceutical preparations for the treatment of pulmonary diseases and disorders; research and development of pharmaceutical preparations and substances for treatment of respiratory conditions; research and development of new products in the field of surfactant replacement therapies for respiratory diseases; research and development of pharmaceutical preparations, namely, pulmonary lung surfactants; pharmaceutical research and development in the field of inhaled pharmaceutical products for all human respiratory indications; research and development services in the field of medical apparatus, appliances and instruments for producing and/or delivering aerosolized pharmaceutical preparations; providing scientific information about pharmaceutical products and services; providing scientific information about pharmaceutical products and services via a website and other forms of mediaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ARAA): This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.

DateCodeEventWhat it means
Feb 6, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 6, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 7, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 7, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 6, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 4, 2017EX1GSOU EXTENSION 1 GRANTED—
Jan 4, 2017EXT1SOU EXTENSION 1 FILED—
Jan 4, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 5, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 18, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 10, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 10, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 20, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 7, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 5, 2016ALIEASSIGNED TO LIE—
Mar 18, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 17, 2016XAECEXAMINER'S AMENDMENT ENTERED—
Mar 17, 2016GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 17, 2016GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 17, 2016CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 16, 2016DOCKASSIGNED TO EXAMINER—
Nov 30, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 27, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance